1-3 of 3
Youn H. Kim
Close
Sort by
Journal Articles

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician’s choice in cutaneous T-cell lymphoma: final data

Clinical Trials & Observations
Steven M. Horwitz, Julia J. Scarisbrick, Reinhard Dummer, Sean Whittaker, Madeleine Duvic, Youn H. Kim, Pietro Quaglino, Pier Luigi Zinzani, Oliver Bechter, Herbert Eradat, Lauren Pinter-Brown, Oleg E. Akilov, Larisa Geskin, Jose A. Sanches, Pablo L. Ortiz-Romero, Michael Weichenthal, David C. Fisher, Jan Walewski, Judith Trotman, Kerry Taylor, Stephane Dalle, Rudolf Stadler, Julie Lisano, Veronica Bunn, Meredith Little, H. Miles Prince
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5098–5106.
https://doi.org/10.1182/bloodadvances.2021004710
Published: 2021
Includes: Supplemental data
Journal Articles

Pembrolizumab in mycosis fungoides with PD-L1 structural variants

Clinical Trials & Observations
Sara Beygi, Sebastian Fernandez-Pol, George Duran, Erica B. Wang, Henning Stehr, James L. Zehnder, Nirasha Ramchurren, Steven P. Fling, Martin A. Cheever, Wen-Kai Weng, Youn H. Kim, Michael S. Khodadoust
Journal: Blood Advances
Blood Adv (2021) 5 (3): 771–774.
https://doi.org/10.1182/bloodadvances.2020002371
Published: 2021
Journal Articles

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Clinical Trials & Observations
Wen-Kai Weng, Sally Arai, Andrew Rezvani, Laura Johnston, Robert Lowsky, David Miklos, Judith Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wang, Timothy Almazan, Lynn Million, Michael Khodadoust, Shufeng Li, Richard T. Hoppe, Youn H. Kim
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4474–4482.
https://doi.org/10.1182/bloodadvances.2020001627
Published: 2020